Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation

Synapse

Volumn 45, Issue 2, 2002, Pages 67-77

  Müller, Christian P ^a   Carey, Robert J ^b   De Souza Silva, Maria A ^a   Jocham, Gerhard ^a   Huston, Joseph P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Behavior; Microdialysis; Serotonin; WAY 100635

Indexed keywords

COCAINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; IN VIVO STUDY; LEARNING; MALE; MICRODIALYSIS; NERVE PROJECTION; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REINFORCEMENT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; EXTRACELLULAR SPACE; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 0036303582     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10083     Document Type: Article

References (92)

1. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro
2. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties
3. Interactions between hippocampal serotonin and the pituitary-adrenal axis in the septal driving of hippocampal theta-rhythm
4. A agonist muscimol
5. Intracellular observations on the disinhibitory action of acetylcholine in the hippocampus
6. Electrophysiological evidence for the tonic activation of the 5-HT1A autoreceptor in vivo in the rat brain
7. Responses of the nucleus accumbens following fornix/fimbria stimulation in the rat. Identification and long-term potentiation of mono- and polysynaptic pathways
8. Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: Possible relevance for the central processing of reward and aversion
9. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region
10. Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: Involvement of the hippocampo-accumbens pathway
11. Release of dopamine in the nucleus accumbens caused by stimulation of the subiculum in freely moving rats
12. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine
13. Modulation of the discriminative stimulus properties of cocaine: Comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists
14. Cocaine stimulant effects: Role of 5-HT1A receptors
15. The 5-HT1A antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine
16. Fluoxetine reduces intravenous cocaine self-administration in rats
17. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens
18. Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells
19. Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin
20. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies
21. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
22. 3 receptors
23. The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: A microanalysis of locomotor activity
24. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat
25. Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences
26. Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens
27. Single-unit recordings from freely-moving animals provide evidence that WAY-100635, but not (S)-WAY-100135, blocks the action of endogenous serotonin at the 5-HT autoreceptor
28. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus
29. Serotonergic control of the hippocampus via local inhibitory interneurons
30. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo micro-dialysis
31. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leucoagglutinin
32. Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus
33. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat
34. Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY100635 into the dorsal and median raphe nuclei of the rat
35. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors
36. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat
37. Amygdala and hippocampus control dissociable aspects of drug-associated conditioned rewards
38. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study
39. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: Relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor
40. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens
41. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus
42. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus
43. Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats
44. Structure and function of the brain serotonin system
45. The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study
46. Hippocampus
47. 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum
48. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde- and retrograde-horseradish peroxidase study
49. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats
50. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist
51. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
52. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
53. Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats
54. Cocaine interaction with central monoaminergic systems: Electrophysiological approaches
55. Effects of 5-HT3, D1 and D2 receptor antagonists on ethanol- and cocaine-induced locomotion
56. Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area
57. 1B/1D antagonists: Chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides
58. Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine
59. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats
60. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity
61. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system
62. 1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine release
63. Ventral tegmental area 5-HT receptors: Mesolimbic dopamine release and behavioural studies
64. Novel 3 alpha-(diphenylmethoxy)tropane analogs: Potent dopamine uptake inhibitors without cocaine-like behavioral profiles
65. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis
66. 1A receptor in the rat brain: Correlation with receptor binding
67. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psycho-stimulant locomotion in rats
68. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine
69. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type-1 receptors in rat brain
70. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice
71. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze
72. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity study
73. Cocaine self-administration in dopamine-transporter knockout mice
74. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor
75. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter
76. Pharmacology of the dendritic action of acetylcholine and further observations on the somatic disinhibition in the rat hippocampus in situ
77. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation
78. Neural connection from hippocampus and nucleus accumbens and the subpallidal area and their contribution to locomotor activity
79. Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens
80. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference
81. 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism
82. Possible novel pharmacodynamic action of cocaine: Cardiovascular and behavioral evidence
83. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats
84. Relapse to cocaine-seeking after hippocampal theta burst stimulation
85. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine
86. Drug-activation of brain reward pathways
87. Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?
88. Neurobiology of cocaine abuse
89. Mesolimbic dopamine terminals and locomotor activity induced from the subiculum
90. Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system
91. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat